Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Product Launch

18 Nov 2005 07:00

Original Investments PLC18 November 2005 Original Investments PLC ("Original Investments" or "the Company") Commercial product launch from Acrobot Visualisation software, enabling orthopaedic surgeons to producethree-dimensional bone surface models from Computed Tomography (CT) scans forpre-operative surgical planning, is launched today by The Acrobot Company("Acrobot"). Acrobot is a spin-out company from Imperial Innovations, the technologycommercialization company of Imperial College, London, and develops surgicalsystems for minimally-invasive, bone-conserving orthopaedic surgery. TheAIM-quoted company Original Investments (formerly BioProjects International)owns 25% of Acrobot's equity. The new software, called the Acrobot(R) Planner, is Acrobot's first commercialproduct and is being provided free of charge to surgeons who register to use it.Acrobot will receive fees for data preparation and bone modeling. The Acrobot(R) Planner gives the user the ability to visualise a patient's threedimensional bone surface models built from CT scans. The visualisation isinteractive and the user can select and position implant models onto the bones,evaluate the resulting range of motion, and produce reports. "The software will enable surgeons to assess accurately the exact requirementfor each operation and precisely plan the procedure beforehand," says Dr. PaulaGomes, Acrobot's Director of Operations. "It will help to reduce surgicalerrors, surgeon's stress, and overall procedure costs and times. Radiologistswill also use the software to produce enhanced reports." Further uses for the software will be as a powerful tool for teaching and alsogenerating visual material for presentations. Acrobot provides a commercial service for Acrobot(R) Planner users by taking theraw CT DICOM data, segmenting them and building bone surface models from theinformation. The user can import these patient-specific models into thesoftware, and perform hip resurfacing pre-operative surgical planning and/ orimpingement analysis. The data processing service removes the need for the userto be involved in time-consuming routine data preparation tasks. The Acrobot(R) Planner has been developed by the Acrobot team at the company'slaboratories in London's Leathermarket. It is the first of a number of relatedproducts to be produced by Acrobot, which was founded six years ago by ImperialInnovations as a collaboration to combine the skills of clinicians andacademics. Acrobot is initially focusing on developing precision surgical systems forminimally-invasive techniques in knee and hip replacement. With each product theoverall aims are to reduce error, increase accuracy and enable more difficultsculpted surfaces to be achieved for the new generation of 'resurfacing' orpartial joint implants. Products planned for launch in 2006 include the Acrobot(R) Navigation System,which provides visual guidance for the surgeon and is now undergoing regulatoryapproval, and the Acrobot Hands-On Robotic System, which has already beensuccessfully proven in clinic for unicompartmental knee arthroplasty. "We are delighted that our faith in Acrobot is beginning to bear commercialfruit," said Terry Bond, managing director of Original Investments. "Four yearsago we were the first investors outside Imperial College to provide seed-cornfunding for the company and we have continued to support it through the variousstages of its development." Further information on Original Investments PLC from Terry Bond, ManagingDirector, 01235 834734. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th May 20114:57 pmRNSExercise of Options & TVR
7th Apr 20118:00 amRNSNew Contract
4th Apr 20117:00 amRNSTrading Update
17th Feb 20114:09 pmRNSExercise of Options and TVR
25th Jan 20117:00 amRNSPlacing to raise £1.25 million
20th Jan 20117:00 amRNSTrading Update
4th Jan 20117:00 amRNSBusiness Update
31st Dec 20107:00 amRNSHalf Yearly Report
17th Nov 20109:15 amRNSTrading Statement
18th Oct 201010:39 amRNSResult of AGM
11th Oct 20107:00 amRNSEnters Offshore Arena with Global Energy Major
20th Sep 20107:00 amRNSFinal Results
14th Sep 20104:30 pmRNSHolding(s) in Company
16th Aug 201012:22 pmRNSExercise of Options & TVR
12th Aug 20107:00 amRNSVialogy Signs Supermajor Contract
12th Jul 20107:00 amRNSGrant of Options
1st Jul 20107:00 amRNSBusiness Update
28th May 20107:00 amRNSTrading Statement
28th Apr 20101:48 pmRNSExercise of Options & TVR
26th Apr 20101:26 pmRNSIssue of Equity & TVR
20th Apr 201011:30 amRNSDirectorate Change
7th Apr 20107:00 amRNSTRADING UPDATE
10th Mar 20107:00 amRNSContract Win
26th Feb 20107:00 amRNSPlacing to raise ?2.9 million
17th Feb 20107:41 amRNSIndependent Analysis of Permian Well results
10th Feb 20102:14 pmRNSExercise of Options/TVR
10th Feb 20107:00 amRNSNEW PERMIAN BASIN WOLFCAMP WELL
3rd Feb 201010:58 amRNSAdditional Listing
29th Jan 201010:08 amRNSExercise of Options & TVR
25th Jan 20101:19 pmRNSExercise of Options
21st Jan 20107:00 amRNSTrading Statement
19th Jan 201011:25 amRNSExercise of Options & TVR
5th Jan 20109:00 amRNSTrading Statement
31st Dec 20097:00 amRNSHalf Yearly Report
15th Dec 200910:41 amRNSExercise of Options & TVR
29th Oct 20093:00 pmRNSGrant of Options
28th Oct 200910:14 amRNSResult of AGM
28th Sep 20097:05 amRNSTrading Update
28th Sep 20097:00 amRNSFinal Results
2nd Sep 20092:39 pmRNSHolding(s) in Company
25th Aug 20092:02 pmRNSExercise of Options and TVR
24th Aug 20095:00 pmRNSHolding(s) in Company
18th Aug 20097:00 amRNSIssue of Equity
14th Aug 200910:47 amRNSHolding(s) in Company
7th Aug 20099:22 amRNSExercise of Options & TVR
23rd Jul 200910:21 amRNSHolding(s) in Company
21st Jul 20099:21 amRNSContract Win
20th Jul 20091:12 pmRNSHolding(s) in Company
17th Jul 20097:00 amRNSAppointment of Broker
15th Jul 20098:42 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.